Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014;4(4):22.
doi: 10.7603/s40681-014-0022-1. Epub 2014 Nov 28.

Retinoic Acid and Cancer Treatment

Affiliations
Free PMC article

Retinoic Acid and Cancer Treatment

Mei-Chih Chen et al. Biomedicine (Taipei). .
Free PMC article

Abstract

Retinoic acid which belongs to the retinoid class of chemical compounds is an important metabolite of vitamin A in diets. It is currently understood that retinoic acid plays important roles in cell development and differentiation as well as cancer treatment. Lung, prostate, breast, ovarian, bladder, oral, and skin cancers have been demonstrated to be suppressed by retinoic acid. Our results also show that low doses and high doses of retinoic acid may respectively cause cell cycle arrest and apoptosis of cancer cells. Also, the common cell cycle inhibiting protein, p27, and the new cell cycle regulator, Cdk5, are involved in retinoic acid's effects. These results provide new evidence indicating that the molecular mechanisms of/in retinoic acid may control cancer cells' fates. Since high doses of retinoic acid may lead to cytotoxicity, it is probably best utilized as a potential supplement in one's daily diet to prevent or suppress cancer progression. In this review, we have collected numerous references demonstrating the findings of retinoic acid in melanoma, hepatoma, lung cancer, breast cancer, and prostate cancer. We hope these observations will shed light on the future investigation of retinoic acid in cancer prevention and therapy.

Keywords: Cancer; Retinoic acid.

Similar articles

See all similar articles

Cited by 25 articles

See all "Cited by" articles

References

    1. Alizadeh F, Bolhassani A, Khavari A, Bathaie SZ, Naji T, Bidgoli SA. Retinoids and their biological effects against cancer. Int Immunopharmacol. 2014;18:43–9. doi: 10.1016/j.intimp.2013.10.027. - DOI - PubMed
    1. Duvic M, Hymes K, Heald P, Breneman D, Martin AG, Myskowski P. et al. Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. J Clin Oncol. 2001;19:2456–71. - PubMed
    1. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A. et al. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med. 1997;337:1021–8. doi: 10.1056/NEJM199710093371501. - DOI - PubMed
    1. Connolly RM, Nguyen NK, Sukumar S. Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment. Clin Cancer Res. 2013;19:1651–9. doi: 10.1158/1078-0432.CCR-12-3175. - DOI - PMC - PubMed
    1. Bushue N, Wan YJ. Retinoid pathway and cancer therapeutics. Adv Drug Deliv Rev. 2010;62:1285–98. doi: 10.1016/j.addr.2010.07.003. - DOI - PMC - PubMed

LinkOut - more resources

Feedback